NON-SMALL CELL LUNG CANCER STAGE I
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE I explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE I trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test detects hidden cancer, guides targeted therapy to stop lung cancer return
Disease control Recruiting nowThis study uses a sensitive blood test (ctDNA) to find tiny amounts of cancer left after standard treatment for early-stage non-small cell lung cancer. If the test is positive, participants receive the drug durvalumab to try to clear the remaining cancer cells and lower the chanc…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo aims to shield scarred lungs from radiation damage
Disease control Recruiting nowThis study tests whether adding BIO 300 to standard chest radiation can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease (lung scarring). About 25 adults will receive the combination and b…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC